Open Implants Announces Gregg M. Gellman as Chief Executive Officer
WOBURN, Mass., February 3, 2021 – The Board of Directors of Open Implants LLC is pleased to announce the appointment of Gregg M. Gellman as the organization’s new Chief Executive Officer. With more than 15 years of experience, leading and growing biomedical companies, Gellman brings a unique and strong skill set to the company.
Gellman’s previous experience includes executive leadership roles at EBI Biomet, now Zimmer Biomet, Greatbatch now Integer Holdings, EnerMed now Garwood Medical, StimMed and Thinking Robot Studios where he will continue to serve as a Board Member for both companies. He has a proven track record in product development, commercialization of regulated applications/products, regulatory and sales. Gellman is a graduate of the State University of New York at Buffalo. He is certified in Quality Systems for Medical Devices (FDA’s QSR and ISO 13485) and in Global Product Submissions Directive Requirements (510(k), PMA, CE Mark).
Read the full press release.